268 related articles for article (PubMed ID: 10704357)
1. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.
Fortin JF; Cantin R; Bergeron MG; Tremblay MJ
Virology; 2000 Mar; 268(2):493-503. PubMed ID: 10704357
[TBL] [Abstract][Full Text] [Related]
2. Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection.
Fortin JF; Barbeau B; Hedman H; Lundgren E; Tremblay MJ
Virology; 1999 Apr; 257(1):228-38. PubMed ID: 10208936
[TBL] [Abstract][Full Text] [Related]
3. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization.
Hioe CE; Bastiani L; Hildreth JE; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S247-54. PubMed ID: 9814951
[TBL] [Abstract][Full Text] [Related]
4. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
5. Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase.
Losier M; Fortin JF; Cantin R; Bergeron MG; Tremblay MJ
Clin Immunol; 2003 Aug; 108(2):111-8. PubMed ID: 12921757
[TBL] [Abstract][Full Text] [Related]
6. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.
Giguère JF; Tremblay MJ
J Virol; 2004 Nov; 78(21):12062-5. PubMed ID: 15479847
[TBL] [Abstract][Full Text] [Related]
7. The importance of virus-associated host ICAM-1 in human immunodeficiency virus type 1 dissemination depends on the cellular context.
Bounou S; Giguere JF; Cantin R; Gilbert C; Imbeault M; Martin G; Tremblay MJ
FASEB J; 2004 Aug; 18(11):1294-6. PubMed ID: 15208262
[TBL] [Abstract][Full Text] [Related]
8. Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins.
Beauséjour Y; Tremblay MJ
Virology; 2004 Jun; 324(1):165-72. PubMed ID: 15183063
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane.
Beauséjour Y; Tremblay MJ
J Infect Dis; 2004 Sep; 190(5):894-902. PubMed ID: 15295693
[TBL] [Abstract][Full Text] [Related]
10. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
[TBL] [Abstract][Full Text] [Related]
11. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
Fortin JF; Cantin R; Tremblay MJ
J Virol; 1998 Mar; 72(3):2105-12. PubMed ID: 9499066
[TBL] [Abstract][Full Text] [Related]
12. Low affinity of cell surface lymphocyte function-associated antigen-1 (LFA-1) generates selectivity for cell-cell interactions.
Ganpule G; Knorr R; Miller JM; Carron CP; Dustin ML
J Immunol; 1997 Sep; 159(6):2685-92. PubMed ID: 9300688
[TBL] [Abstract][Full Text] [Related]
13. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
Bounou S; Leclerc JE; Tremblay MJ
J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
[TBL] [Abstract][Full Text] [Related]
14. Effect of antibody valency on interaction with cell-surface expressed HIV-1 and viral neutralization.
Cavacini LA; Emes CL; Power J; Duval M; Posner MR
J Immunol; 1994 Mar; 152(5):2538-45. PubMed ID: 7510748
[TBL] [Abstract][Full Text] [Related]
15. Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.
Paquette JS; Fortin JF; Blanchard L; Tremblay MJ
J Virol; 1998 Nov; 72(11):9329-36. PubMed ID: 9765484
[TBL] [Abstract][Full Text] [Related]
16. Enhanced HIV type 1 neutralization by human anti-glycoprotein 120 monoclonal antibodies in the presence of monoclonal antibodies to lymphocyte function-associated molecule 1.
Hioe CE; Hildreth JE; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1999 Apr; 15(6):523-31. PubMed ID: 10221529
[TBL] [Abstract][Full Text] [Related]
17. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.
Barbeau B; Fortin JF; Genois N; Tremblay MJ
J Virol; 1998 Sep; 72(9):7125-36. PubMed ID: 9696806
[TBL] [Abstract][Full Text] [Related]
19. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization.
Rizzuto CD; Sodroski JG
J Virol; 1997 Jun; 71(6):4847-51. PubMed ID: 9151884
[TBL] [Abstract][Full Text] [Related]
20. Increased infectivity of HIV type 1 particles bound to cell surface and solid-phase ICAM-1 and VCAM-1 through acquired adhesion molecules LFA-1 and VLA-4.
Liao Z; Roos JW; Hildreth JE
AIDS Res Hum Retroviruses; 2000 Mar; 16(4):355-66. PubMed ID: 10716373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
